Chloroethylnitrosoureas (CENUs) are alkylating and crosslinking agents used for the treatment of human cancer; they are both mutagenic and carcinogenic. We compared the levels of induction of sister chromatid exchanges (SCEs) and the cytotoxicity of nitrosoureas that alkylate only with CENUs. CENUs are 200-fold more cytotoxic and induce SCEs with 45-fold greater efficiency than agents that do not crosslink; therefore, crosslinking is probably the most important molecular event that leads to cell death and induction of SCEs.
Introduction
2-Chloroethyl-l-nitrosoureas (CENUs), synthesized first by Montgomery and co-workers, are cytotoxic agents effective against a wide variety of in vitro and in vivo tumor model systems (1, 2) . Currently these compounds are being used clinically to treat a variety of human tumors (3, 4) . In addition to their cytotoxic effects, these agents have been shown to be mutagenic in both prokaryotic (5) and eukaryotic test systems (6) and to induce tumors in rats (7, 8) . Consequently, in addition to their therapeutic benefit they may pose a genotoxic hazard to the treated patient (9, 10) . Therefore it is very important that a clear understanding of the biochemical processes mediating the cytotoxic, mutagenic effects, and carcinogenic effects of these compounds be obtained.
Under physiological conditions, CENUS are hydrolyzed to reactive species that alkylate cellular DNA, RNA, and proteins (11) . Some products may form DNA interstrand crosslinks in subsequent reactions (12, 13) . DNA interstrand crosslink formation is thought to cause the cytotoxic effects of CENUs (14) (15) (16) . One of the crosslinks formed in DNA treated with CENUs has been identified as [1-(N-3- deoxycytidyl)-2-(N-1-deoxyguanosinyl)ethane] (13) . Tong and Ludlum (13) postulated that the formation of 06-2-chloroethylguanine is the initial alkylation event that leads to the subsequent formation of this DNA crosslink. This hypothesis is supported by the observation that cells that can remove 06-methylguanine (O6MeG) from their DNA are resistant to the cytotoxic effects of CENUs and have fewer DNA interstrand crosslinks formed after treatment with CENUs (14) (15) (16) .
The enzyme that repairs 06-alkylguanine in DNA is 06-methylguanine DNA methyltransferase (17) (18) (19) , a receptor protein that catalyzes the dealkylation of O6-alkylguanine in DNA to produce the alkylated protein and guanine (17) (18) (19) . The transferase is inactivated after a single event (17) (18) (19) . Human (20) (21) (22) (23) (14) (15) (16) (24) (25) (26) (27) .
Resistance of cells to the cytotoxic effects of chemotherapeutic agents appears to be one cause of the ineffectiveness of chemotherapy for human cancer (28, 29) . Approximately 60% ofhuman brain tumors are resistant to the therapeutic effects of BCNU (30, 31) . Studies of the properties of cell lines that are resistant to chemotherapeutic agents may help define more fully the molecular mechanisms involved in cellular resistance.
Currently a number of rodent derived cell lines are used to test the effects of chemotherapeutic agents. One of these, 9L, is a well characterized gliosarcoma cell line that has been used for both in vivo and in vitro cytotoxicity studies (32) . CENU-resistant sublines have been isolated from the 9L cell line (29) . We have begun a study of the mechanisms of resistance to CENUs using one of these sublines, 9L-2, and cell lines derived from human brain tumors (33) .
Cell Killing and SCE Induction Caused by CENUs
The cytotoxic effect of nitrosoureas have been investigated by using a colony-forming assay, which has been described in detail (14, 33) . For our studies we have compared the cytotoxic effects in 9L cells treated with the alkylating agent 1-ethyl-1-nitrosourea (ENU) and 3-(4-amino)-2-methyl-5-pyrimidinyl-methyl-1-(2-chloroethyl)-1-nitrosourea (ACNU), an agent that both alkylates and crosslinks DNA. The structures of these nitrosoureas are shown in We compared the relative efficiency with which ACNU and ENU induce sister chromatid exchanges (SCEs). SCEs are reciprocal exchanges formed between sister chromatids during DNA replication (34) (35) (36) , and a correlation between induction of SCEs and cytotoxicity has been reported (14, 37, 38) . Induction of SCEs in 9L cells was measured by using the procedure of Perry and Wolff (39) . Treatment of 9L cells with 2 ,uM ACNU induced approximately 30 SCEs/metaphase (Fig. 3A) . A linear dose-response relationship was found, and the slope of the dose response curve was calculated to be 15.8 SCEs/ ,uM ACNU by linear regression analysis. ENU treatment also produced a linear dose response curve (Fig.  3B) , the slope of which was 0.11 SCEs/,uM ENU. Thus, based on the ratio of the slopes for the dose-response curves, ACNU is 143-fold more efficient at inducing SCEs than is ENU. The differential induction of SCEs caused by ENU and ACNU may be the result of different levels of alkylation of cellular DNA, which may be mediated by different rates of cellular uptake or hydrolysis for the two compounds. Alkylation of cellular DNA with both 14C-ENU and 14C-ACNU was linear over the concentration ranges studied (Fig. 4) (40, 41) . The alkylation products identified are listed in Table 1 . The DNA alkylation products formed by CENU treatment of purified DNA have been extensively investigated (13, (42) (43) (44) (45) (46) . Even though the alkylation products in cells treated with CENUs have not been quantitated, the alkylation products of purified Table 1 . The alkylation products formed by ENU and CENUs are very similar. The primary difference is that chloroethyl product(s) of CENUs can crosslink bases on the same or opposite strands in subsequent reactions (13, 44, 45) . It has been suggested that the crosslinked base 1,2-(dideoxyguanosine-7-yl)ethane is a DNA intrastrand crosslink (44) and that 1-(N-3-deoxycytidyl)-2-(N-1-deoxyguanosinyl)ethane is a DNA interstrand crosslink (13, 45) . Thus, the 45-fold differential induction of SCEs and 200-fold increased cytotoxicity caused by ACNU is probably the result of DNA interstrand crosslink formation. 
Cellular Resistance
Cellular resistance to the cytotoxic effects of CENUs appears to be one of the major factors for the ineffectiveness of CENUs in the treatment of human cancer. To study this process in detail, we isolated sublines of 9L by high dose treatment of rats bearing the intracerebral 9L tumor with 1,3 bis(2-chloroethyl)-1-nitrosourea (BCNU) (29) . Established cell lines from human brain tumors were used also.
Survival plots for 9L and 9L-2 cells treated with various concentrations of the DNA crosslinking agent BCNU are shown in Figure 5 . 9L-2 cells are markedly more resistant to the cytotoxic effects of BCNU than are 9L cells; 90% of the 9L cells cannot form colonies after a 1-hr treatment with 30 ,uM of BCNU. In contrast, 9L-2 cells must be treated with 120 ,uM of BCNU to achieve the same level of cell kill. Thus 9L-2 cells are at least 4-fold more resistant to the cytotoxic effects of BCNU than are 9L cells.
As found for ACNU, BCNU efficiently induces SCEs in 9L cells; the dose-response curve is linear (Fig. 6A ) with a slope of 13.5 SCEs/,uM BCNU. However, very few SCEs are induced in 9L-2 cells treated over the same dose range (Fig. 6A) . To induce similar levels of SCEs in both cell lines, 9L-2 cells have to be treated with a 10-fold higher dose of BCNU (Fig. 6B) . The slope of the dose-response curve for SCE induction on 9L-2 cells is 0.93 SCEs/4aM BCNU. As calculated by the ratio of the slopes of the dose-response plots, 9L-2 cells are 14-fold less susceptible to the induction of SCEs than are 9L cells.
Dose-response curves for BCNU treatment in the cell lines derived from three human brain tumors are presented in Figure 7 . HU-126 cells are very sensitive to the cytotoxic effects of BCNU compared to either HU-188 or HU-253-2 cells. The induction of SCEs by BCNU treatment has also been measured in these human cell lines (Fig. 7) 
DNA Repair and Resistant Cells
Recently published data (14) (15) (16) suggest that a relationship exists between the repair of 06-alkylguanine derivatives and cellular resistance to CENUs in human tumor cells. We have examined the possibility that a similar mechanism is responsible for the observed resistance of 9L-2, HU-188, and HU-253-2 cells to SCE induction and cytotoxicity. For our studies we treated these cells with 100 ,uM 3H-MNU, a dose of MNU that does not saturate the methyltransferase activity in Mex+ cells (21) . The extent of methylation of DNA in all of the cell lines after a 1-hr treatment with 100 ,uM 3H-MNU was very similar ( Table 2 ). The formation of N-3-MeA and N-7-MeG was also the same in these cell lines. The 06-MeG/N-7-MeG ratio in 9L and HU-126 cells was similar to values reported for other cell lines that do not repair 06-MeG (20) . In contrast, the 06-MeG/ N-7 MeG ratio in 9L-2 cells was 0.094, approximately 20% lower than in 9L. In HU-188, and HU-253-2 cells the 06-MeG/N-7 MeG ratio was 0.067, and 0.043, respectively. Because 06-MeG is a stable alkylation product of DNA, the lower 06-MeG/N-7-MeG ratio in 9L-2, HU-188, and HU-253-2 cells represents repair of O6-MeG by these cells during the 1-hr treatment period.
These (Table 3 ). In contrast, HU-188 and HU-253-2 cells have 3-to 5-fold higher levels of this enzyme. These results correlate very well with the removal of 06-MeG in the human cell lines treated with 3H-MNU ( Table 2) .
Because results of earlier studies indicate that DNA interstrand crosslinks formed after CENU treatment are responsible for both cell killing and SCE induction, we compared the number of DNA interstrand crosslinks formed in sensitive and resistant cells after BCNU treatment. We used the technique of alkaline elution developed by Kohn and co-workers (1 7) to estimate the number of interstrand crosslinks formed in treated cells. The relative number of DNA interstrand crosslinks formed in cells after treatment with either 50 or 100 ,uM BCNU for 1 hr, followed by a 6-hr incubation period, aThe number of proteinase K-resistant DNA crosslinks was determined as described (14) . Figure 8 . Resistant cells have an increased capacity to remove 06-(2-chloroethyl)guanine in DNA. Enzymatic removal of this alkylation product will reduce DNA crosslink formation and therefore should reduce both SCE induction and the cytotoxic effect of CENU treatment. In contrast, sensitive cells have a very poor capacity to remove 06_ (2-chloroethyl)guanine derivatives. Therefore, in these cells, DNA crosslink formation will occur that leads to SCE formation and cell kill. In agreement with this hypothesis, Robbins et al. (48) and Brent (49) (50) . Recently, the mutagenicity of CENUs has been investigated. These compounds have been shown to induce mutations in both prokaryotic (5) and eukaryotic test systems (6) . The molecular mechanism for the mutagenic effect of alkyl nitrosoureas has been attributed to their capacity to form the 0-alkylpurine and 0-alkylpyrimidine derivatives listed in Table 1 . These alkylation products have been shown to cause misincorporation of non-Watson-Crick base pairing partners in in vitro systems (51) (52) (53) (54) . CENUs have been shown to form O6-(2-hydroxyethyl)deoxyguanosineand3,N4-ethanodeoxycytidine in DNA. These alkylation products probably induce mutations by a mechanism that leads to misincorporation.
CENUs have been shown to induce tumors, primarily lung tumors, leukemias, and lymphosarcomas, when administered to either mice or rats (7, 8) . Patients undergoing chemotherapy receive doses up to 1.5 g/m2. Clinical evidence has been presented that treatment of patients with CENUs may cause secondary leukemias (9, 10) . There is very good evidence that DNA repair plays a major role in organ-specific carcinogenesis. Investigations with nitrosoureas and nitrosoamines have shown that the cellular capacity to remove 06-alkylguanine and 04-alkyl thymidine is inversely related to the susceptibility of the organ to the tumorigenic effect of these compounds (55) (56) (57) (58) (59) (60) . Therefore the cellular capacity to remove the 06-alkylguanine derivatives produced by CENU treatment should modify the carcinogenic effects of these agents. Cellular repair of 06-alkylguanine derivatives formed by CENUs may have two major effects: it prevents the formation of a DNA crosslink and hence reduces the cytotoxic effect of CENU treatment, and it removes the promutagenic base and reduces the carcinogenic effect of the compounds. 
